LITERATURA CIENTIFICA DE RESPALDO EN ONCOLOGIA MOLECULAR E INMUNOTERAPIA

Destacada en distintas publicaciones por ser 1 de las 3 inmunoterapias (junto a T-CAR e inhibidores de checkpoints) con mayor respaldo, así como alta precisión, personalizada, de mínimas reacciones adversas y de costo más accesible en comparación a otras inmunoterapias.

Robert A. Belderbos,1,2 Joachim G.J.V. Aerts,1,2 and Heleen Vroman1,2

Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment (2019): Enhancing Dendritic Cell Therapy in Solid Tumors Department of Pulmonary Medicine, Erasmus MC Rotterdam, the Netherlands; 2Erasmus MC Cancer Institute, Erasmus MC Rotterdam, the Netherlands

DOI: Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment (2019):

By Hanne Locy, Sarah Melhaoui, Sarah K. Maenhout and Kris Thielemans

Dendritic Cells: The Tools for Cancer Treatment: Submitted: April 6th 2018Reviewed: June 4th 2018Published: November 5th 2018 DOI: 10.5772/intechopen.79273 Dendritic Cells: The Tools for Cancer Treatment

DOI: Hanne Locy, Sarah Melhaoui, Sarah K. Maenhout and Kris Thielemans (November 5th 2018). Dendritic Cells: The Tools for Cancer Treatment, Dendritic Cells, Svetlana P. Chapoval, IntechOpen, DOI: 10.5772/intechopen.79273. Available from: https://www.intechopen.com/chapters/63198

Abhishek D. Garg Pierre G. Coulie Benoit J. Van den Eynde Patrizia Agostinis

Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape.: Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape The field of cancer immunotherapy is experiencing a renaissance spearheaded by ICIs and ACTs.

DOI: https://doi.org/10.1016/j.it.2017.05.006